myofascial pain syndrome
Conditions
Interventions
Normal Group(Group N):Trigger point corresponding parts biopsy
Biopsy Group:Trigger point biopsy and Compound long - acting analgesic drug injection
Injection Group:Compound long - acting analgesic drug injection
Sponsors
Qilu Hospital of Shandong University
Eligibility
Sex/Gender
All
Age
20 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1) aged 20-70 years; 2) with a dignosed myofascial pain syndrome; 3) whose myofascial trigger points are located in upper trapezius; 4) with chronic pain lasted longer than 2 months; 5) whose skin of injection has on infection; 6) subjects or their legal guardians have signed informed consent.
Exclusion criteria
Exclusion criteria: 1) patients'pain is resulted from neoplasm metastasis; 2) patients suffered from sepsis; 3) patients suffered from coagution disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS score (before therapy, 10minute, 1week, 4week, 8week);Yellow value(immunohistochemistry);The fluorescence intensity;Absorbance at 490nm; | — |
Countries
China
Contacts
Public ContactFeng Qi
Qilu Hospital of Shandong University
Outcome results
None listed